Io vitro susceptibility of Mycobacterium tuberculosis to fusidic acid


Cicek-Saydam C. , Cavusoglu C. , Burhanoglu D., Hilmioglu S., OZKALAY N., BILGIC A.

CLINICAL MICROBIOLOGY AND INFECTION, vol.7, no.12, pp.700-702, 2001 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 12
  • Publication Date: 2001
  • Doi Number: 10.1046/j.1469-0691.2001.00341.x
  • Title of Journal : CLINICAL MICROBIOLOGY AND INFECTION
  • Page Numbers: pp.700-702

Abstract

The aim of this study was to determine the in vitro susceptibility of 170 clinical isolates of Mycobacterium tuberculosis to fusidic acid using a proportion dilution method. Nineteen isolates were resistant to at least one first line anti-tuberculosis drug. A total of 1.8% of the isolates were resistant to fusidic acid. Fusidic acid should be evaluated clinically as a potential supplementary drug for the treatment of infections due to multidrug-resistant strains of M. tuberculosis.